New Delhi: Jawed Zia has been appointed as the new Chief Executive Officer of Cadila Pharmaceuticals. Zia will lead the strategy and business operations of Cadila’s branded prescriptions pharmaceuticals business.
A seasoned industry professional with more than three-and-a-half decades of experience, he last served as vice chairman of healthcare start-up Rivaara Holdings.
A strategic thinker with versatile experience, Zia has deep knowledge and extensive experience in building and managing businesses in the healthcare industry. His innate ability to drive the growth of people and businesses, build brands, transform operations and scale capabilities has been the hallmark of his success.
A graduate of Clinical Pharmacology from the All India Institute of Medical Sciences, New Delhi, Zia studied business administration at Trinity College, Dublin. He joined Novartis in 1987 and had a successful career passing over 30 years across market research, brand management, marketing, and other functions in Ireland, Singapore, Saudi Arabia, Canada, Switzerland, Turkey, and India. His experience includes roles in Rx Pharmaceuticals, consumer health and medical devices and Instrumentations. He also led Abbott India operations.
